lyleq
Generic: norethindrone
Labeler: afaxys pharma, llcDrug Facts
Product Profile
Brand Name
lyleq
Generic Name
norethindrone
Labeler
afaxys pharma, llc
Dosage Form
TABLET
Routes
Active Ingredients
norethindrone .35 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50102-300
Product ID
50102-300_ffb8f5fe-9e1a-4ca9-adc9-181093af01b9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207304
Listing Expiration
2026-12-31
Marketing Start
2016-09-23
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50102300
Hyphenated Format
50102-300
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lyleq (source: ndc)
Generic Name
norethindrone (source: ndc)
Application Number
ANDA207304 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .35 mg/1
Packaging
- 3 PACKAGE in 1 CARTON (50102-300-13) / 1 BLISTER PACK in 1 PACKAGE (50102-300-11) / 28 TABLET in 1 BLISTER PACK (50102-300-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ffb8f5fe-9e1a-4ca9-adc9-181093af01b9", "openfda": {"nui": ["M0447349", "N0000175602"], "unii": ["T18F433X4S"], "rxcui": ["198042", "748961", "2397128"], "spl_set_id": ["c9f00a3e-c827-4066-bf85-079b3a20f25e"], "pharm_class_cs": ["Progesterone Congeners [CS]"], "pharm_class_epc": ["Progestin [EPC]"], "manufacturer_name": ["Afaxys Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 PACKAGE in 1 CARTON (50102-300-13) / 1 BLISTER PACK in 1 PACKAGE (50102-300-11) / 28 TABLET in 1 BLISTER PACK (50102-300-01)", "package_ndc": "50102-300-13", "marketing_start_date": "20160923"}], "brand_name": "Lyleq", "product_id": "50102-300_ffb8f5fe-9e1a-4ca9-adc9-181093af01b9", "dosage_form": "TABLET", "pharm_class": ["Progesterone Congeners [CS]", "Progestin [EPC]"], "product_ndc": "50102-300", "generic_name": "NORETHINDRONE", "labeler_name": "Afaxys Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lyleq", "active_ingredients": [{"name": "NORETHINDRONE", "strength": ".35 mg/1"}], "application_number": "ANDA207304", "marketing_category": "ANDA", "marketing_start_date": "20160923", "listing_expiration_date": "20261231"}